The Latest Breaking News from Co

Live cattle futures posted mixed trade with nearbys within 15 cents of unchanged and deferred contracts higher. Cash trade has been slow this week, with some northern dressed action at $385 and live trade at $245. The Thursday Fed Cattle Exchange online auction showed no sales on the 1,264 head,...

As food prices continue to soar, we look at which supermarket has the best value meal deal

Novo Nordisk A/S (NYSE:NVO) has reportedly imposed a global hiring freeze for nonessential roles, as the drugmaker faces rising competition from copycat versions of Wegovy and intensifying rivalry with Eli Lilly and Co (NYSE:LLY).

Among nearly 1,400 suspects held, Steven Barrs targeted same Notting Hill branch of Co-op 15 times

Time to Say Goodbye topped the list of top songs to be played at funerals

The theme tune for Jaws is one of the more unusual requests.

On Tuesday, Viking Therapeutics Inc. (NASDAQ:VKTX) released the much-awaited data from its Phase 2 trial of VK2735 pill, the company’s dual agonist of the glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors.

The figure is down from July’s 5.2% – which represented a rise from inflation of 4.7% a month earlier and marked the highest level since January 2024.

GoodRx Holdings Inc. (NASDAQ:GDRX) shares jumped 5.08% in after-hours trading on Monday, following the announcement of a collaboration with Novo Nordisk A/S (NYSE:NVO) to offer discounted GLP-1 medications at fixed pricing nationwide.

Other lives: Journalist on the Daily Mirror who co-founded the Greyhound Star newspaper before moving into book publishing

GoodRx Holdings Inc. (NASDAQ:GDRX) announced that, via a collaboration with Novo Nordisk A/S (NYSE:NVO), all strengths of Ozempic (semaglutide) and Wegovy (semaglutide) pens are available to eligible self-paying patients for $499-per-month through GoodRx, effective immediately.